Tuesday, January 24, 2017

Subclavian TAVR Safe When Femoral Access Is Risky

(MedPage Today) -- CoreValve trial analysis shows similar morbidity, mortality
via Subclavian TAVR Safe When Femoral Access Is Risky
by

No comments:

Post a Comment